#CHROM	POS	REF	ALT	Gene_ID	Gene_name	HGVSc	HGVSg	Intron_number	gnomADg_AF	Effect_category	Functional_consequence	Phenotype (OMIM)	Source
14	92441435	A	T	ENSG00000100815	TRIP11	ENST00000267622.4:c.5457+81T>A	14:g.92441435A>T	18/20	.	strengthening_donor	77bp_exon_extension	Achondrogenesis type IA (200600)	pbarbosa_2022
14	92441439	A	C	ENSG00000100815	TRIP11	ENST00000267622.4:c.5457+77T>G	14:g.92441439A>C	18/20	.	new_splice_donor	97bp_exon_extension	Achondrogenesis type IA (200600)	pbarbosa_2022
8	87617644	C	T	ENSG00000170289	CNGB3	ENST00000320005.5:c.1663-1205G>A	8:g.87617644C>T	14/17	.	strengthening_donor	34bp_pseudoexon_inclusion	Achromatopsia (262300)	pbarbosa_2022
8	87674402	T	A	ENSG00000170289	CNGB3	ENST00000320005.5:c.852+4751A>T	8:g.87674402T>A	6/17	.	strengthening_acceptor	73bp_pseudoexon_inclusion	Achromatopsia (262300)	pbarbosa_2022
8	87618576	G	A	ENSG00000170289	CNGB3	ENST00000320005.5:c.1663-2137C>T	8:g.87618576G>A	14/17	.	new_splice_donor	99bp_pseudoexon_inclusion	Achromatopsia (262300)	pbarbosa_2022
3	120396773	T	G	ENSG00000113924	HGD	ENST00000283871.5:c.16-2063A>C	3:g.120396773T>G	1/13	3.183700027875602e-05	change_sre	126bp_pseudoexon_inclusion	Alkaptonuria (203500)	pbarbosa_2022
2	227952667	A	T	ENSG00000081052	COL4A4	ENST00000396625.3:c.1623+702T>A	2:g.227952667A>T	22/47	.	strengthening_donor	109bp_pseudoexon_inclusion	Alport syndrome (203780)	pbarbosa_2022
2	228009296	GATTA	G	ENSG00000081052	COL4A4	ENST00000396625.3:c.72-26_72-23del	2:g.228009300_228009303del	2/47	.	branchpoint_associated	exon_skipping	Alport syndrome (203780)	pbarbosa_2022
X	107820081	A	G	ENSG00000188153	COL4A5	ENST00000328300.6:c.609+879A>G	X:g.107820081A>G	10/52	.	new_splice_donor	128bp_pseudoexon_inclusion	Alport Syndrome (301050)	pbarbosa_2022
X	107851397	C	G	ENSG00000188153	COL4A5	ENST00000328300.6:c.2395+1275C>G	X:g.107851397C>G	29/52	.	branchpoint_associated	53bp_pseudoexon_inclusion	Alport Syndrome (301050)	pbarbosa_2022
X	107851414	G	T	ENSG00000188153	COL4A5	ENST00000328300.6:c.2395+1292G>T	X:g.107851414G>T	29/52	.	strengthening_acceptor	53bp_pseudoexon_inclusion	Alport Syndrome (301050)	pbarbosa_2022
X	107811300	A	G	ENSG00000188153	COL4A5	ENST00000328300.6:c.277-559A>G	X:g.107811300A>G	4/52	.	change_sre	58bp_pseudoexon_inclusion	Alport Syndrome (301050)	pbarbosa_2022
9	135173806	T	C	ENSG00000107290	SETX	ENST00000224140.5:c.5549-107A>G	9:g.135173806T>C	12/25	.	strengthening_donor	73bp_pseudoexon_inclusion	Ataxia with Oculomotor Apraxia 2 (606002)	pbarbosa_2022
11	108123274	T	G	ENSG00000149311	ATM	ENST00000278616.4:c.1803-270T>G	11:g.108123274T>G	11/62	.	strengthening_donor	56bp_pseudoexon_inclusion	Ataxia-telangiectasia (208900)	pbarbosa_2022
9	86590455	T	C	ENSG00000165119	HNRNPK	ENST00000376263.3:c.214-35A>G	9:g.86590455T>C	5/16	.		intron_retention	Au-Kline syndrome (616580)	pbarbosa_2022
8	61757392	C	T	ENSG00000171316	CHD7	ENST00000423902.2:c.4851-31C>T	8:g.61757392C>T	21/37	0.0001910599967231974	change_sre	32bp_exon_extension	Autism Disorder (209850)	pbarbosa_2022
X	31899369	T	C	ENSG00000198947	DMD	ENST00000357033.4:c.6913-5879A>G	X:g.31899369T>C	47/78	.	new_splice_donor	134bp_pseudoexon_inclusion	Becker muscular dystrophy (300376)	pbarbosa_2022
X	32662831	G	A	ENSG00000198947	DMD	ENST00000357033.4:c.1149+250C>T	X:g.32662831G>A	10/78	.	new_splice_donor	141bp_pseudoexon_inclusion	Becker muscular dystrophy (300376)	pbarbosa_2022
X	32477825	C	A	ENSG00000198947	DMD	ENST00000357033.4:c.3432+3731G>T	X:g.32477825C>A	25/78	.	new_splice_donor	66bp_pseudoexon_inclusion	Becker muscular dystrophy (300376)	pbarbosa_2022
X	31279780	T	C	ENSG00000198947	DMD	ENST00000357033.4:c.9225-647A>G	X:g.31279780T>C	62/78	.	new_splice_donor	67bp_pseudoexon_inclusion	Becker muscular dystrophy (300376)	pbarbosa_2022
X	32187215	C	A	ENSG00000198947	DMD	ENST00000357033.4:c.6438+47818G>T	X:g.32187215C>A	44/78	.	strengthening_acceptor	92bp_pseudoexon_inclusion	Becker muscular dystrophy (300376)	pbarbosa_2022
15	91337139	A	G	ENSG00000197299	BLM	ENST00000355112.3:c.3020-258A>G	15:g.91337139A>G	15/21	.	new_splice_donor	166bp_pseudoexon_inclusion	Bloom Syndrome (210900)	pbarbosa_2022
9	94539066	A	G	ENSG00000169071	ROR2	ENST00000375708.3:c.98-966T>C	9:g.94539066A>G	1/8	.			Brachydactyly syndrome, type B1 (113000)	pbarbosa_2022
9	21968795	A	C	ENSG00000147889	CDKN2A	ENST00000498124.1:c.458-25T>G	9:g.21968795A>C	2/3	.	branchpoint_associated	exon_skipping	Breast cancer (114480)	pbarbosa_2022
8	75272349	A	G	ENSG00000104381	GDAP1	ENST00000220822.7:c.311-23A>G	8:g.75272349A>G	2/5	.	new_splice_acceptor	22bp_exon_extension	Charcot-Marie-Tooth disease (607831)	pbarbosa_2022
11	68697719	C	A	ENSG00000132740	IGHMBP2	ENST00000255078.3:c.1235+894C>A	11:g.68697719C>A	8/14	.	new_splice_acceptor	182bp_pseudoexon_inclusion	Charcot-Marie-Tooth disease (616155)	pbarbosa_2022
5	60223572	C	G	ENSG00000049167	ERCC8	ENST00000265038.5:c.173+1119G>C	5:g.60223572C>G	2/11	6.375899829436094e-05	change_sre	348bp_pseudoexon_inclusion	Cockayne syndrome (216400)	pbarbosa_2022
10	55597057	A	C	ENSG00000150275	PCDH15	ENST00000361849.3:c.3983+3023T>G	10:g.55597057A>C	29/33	.	new_splice_acceptor	29bp_pseudoexon_inclusion	Cone-rod dystrophy (120970)	pbarbosa_2022
14	21793624	A	G	ENSG00000092200	RPGRIP1	ENST00000400017.2:c.2367+82A>G	14:g.21793624A>G	15/23	0.0003502700128592551	new_splice_donor	81bp_exon_extension	Cone-rod dystrophy (608194)	pbarbosa_2022
4	15989860	T	C	ENSG00000007062	PROM1	ENST00000510224.1:c.2077-521A>G	4:g.15989860T>C	19/27	.	new_splice_donor	155bp_pseudoexon_inclusion	Cone-rod dystrophy (612657)	pbarbosa_2022
4	56284334	G	A	ENSG00000134851	TMEM165	ENST00000381334.5:c.792+182G>A	4:g.56284334G>A	4/5	3.1840998417465016e-05	strengthening_donor	117bp_pseudoexon_inclusion	Congenital Disorder of Glycosylation (614726)	pbarbosa_2022
14	81574926	C	A	ENSG00000165409	TSHR	ENST00000541158.2:c.692+130C>A	14:g.81574926C>A	9/10	.		120bp_pseudoexon_inclusion	Congenital hypothyroidism (275200)	pbarbosa_2022
12	21604039	A	G	ENSG00000121350	PYROXD1	ENST00000240651.9:c.415-976A>G	12:g.21604039A>G	4/11	.	strengthening_donor	110bp_pseudoexon_inclusion	Congenital myopathy (617258)	pbarbosa_2022
5	37012396	C	T	ENSG00000164190	NIPBL	ENST00000282516.8:c.4560+2069C>T	5:g.37012396C>T	21/46	.	new_splice_donor	pseudoexon_inclusion	Cornelia de Lange syndrom (122470)	pbarbosa_2022
5	37031001	C	T	ENSG00000164190	NIPBL	ENST00000282516.8:c.5862+3487C>T	5:g.37031001C>T	32/46	.	new_splice_donor	118bp_pseudoexon_inclusion	Cornelia de Lange syndrome (122470)	pbarbosa_2022
5	36975238	G	C	ENSG00000164190	NIPBL	ENST00000282516.8:c.869-640G>C	5:g.36975238G>C	8/46	.		95bp_pseudoexon_inclusion	Cornelia de Lange syndrome (122470)	pbarbosa_2022
7	117288374	A	G	ENSG00000001626	CFTR	ENST00000003084.6:c.3874-4522A>G	7:g.117288374A>G	23/26	.	new_splice_acceptor	125bp_pseudoexon_inclusion	Cystic Fibrosis (2197700)	pbarbosa_2022
7	117229521	A	G	ENSG00000001626	CFTR	ENST00000003084.6:c.1680-886A>G	7:g.117229521A>G	12/26	.	new_splice_donor	49bp_pseudoexon_inclusion	Cystic Fibrosis (2197700)	pbarbosa_2022
X	32535101	C	A	ENSG00000198947	DMD	ENST00000357033.4:c.2292+1024G>T	X:g.32535101C>A	18/78	.	new_splice_donor	161bp_pseudoexon_inclusion	Duchenne muscular dystrophy (310200)	pbarbosa_2022
X	32407106	A	T	ENSG00000198947	DMD	ENST00000357033.4:c.4518+512T>A	X:g.32407106A>T	32/78	.	new_splice_acceptor	167bp_pseudoexon_inclusion&172bp_pseudoexon_inclusion	Duchenne muscular dystrophy (310200)	pbarbosa_2022
X	32366456	T	C	ENSG00000198947	DMD	ENST00000357033.4:c.5448+67A>G	X:g.32366456T>C	38/78	.	new_splice_donor	67bp_exon_extension	Duchenne muscular dystrophy (310200)	pbarbosa_2022
X	32360889	T	C	ENSG00000198947	DMD	ENST00000357033.4:c.5739+362A>G	X:g.32360889T>C	40/78	.	new_splice_donor	78bp_pseudoexon_inclusion	Duchenne muscular dystrophy (310200)	pbarbosa_2022
X	32471959	C	A	ENSG00000198947	DMD	ENST00000357033.4:c.3603+820G>T	X:g.32471959C>A	26/78	.	branchpoint_associated	84bp_pseudoexon_inclusion	Duchenne muscular dystrophy (310200)	pbarbosa_2022
X	31200680	A	T	ENSG00000198947	DMD	ENST00000357033.4:c.9974+175T>A	X:g.31200680A>T	68/78	.	strengthening_donor	88bp_pseudoexon_inclusion	Duchenne muscular dystrophy (310200)	pbarbosa_2022
X	153787731	C	T	ENSG00000073009	IKBKG 	ENST00000369609.5:c.722+866C>T	X:g.153787731C>T	4/9	.	strengthening_donor	44bp_pseudoexon_inclusion	EDA-ID (300291)	pbarbosa_2022
2	166863768	A	G	ENSG00000144285	SCN1A	ENST00000303395.4:c.4002+2461T>C	2:g.166863768A>G	20/25	.	change_sre	64bp_pseudoexon_inclusion	Epilepsy (604403)	pbarbosa_2022
3	10184641	T	C	ENSG00000134086	VHL	ENST00000256474.2:c.340+770T>C	3:g.10184641T>C	1/2	3.1858999136602506e-05		259bp_pseudoexon_inclusion	Erythrocytosis (263400)	pbarbosa_2022
3	10184687	A	C	ENSG00000134086	VHL	ENST00000256474.2:c.340+816A>C	3:g.10184687A>C	1/2	.		259bp_pseudoexon_inclusion	Erythrocytosis (263400)	pbarbosa_2022
18	55238820	A	G	ENSG00000066926	FECH	ENST00000262093:c.315-48T>C	18:g.55238820A>G	3/10	0.06650000065565109	change_sre	63bp_exon_extension	Erythropoietic Protoporphyria (177000)	pbarbosa_2022
18	55234982	T	G	ENSG00000066926	FECH	ENST00000262093.5:c.464-1169A>C	18:g.55234982T>G	4/10	.	change_sre	156bp_pseudoexon_inclusion	Erythropoietic Protoporphyria (177000)	pbarbosa_2022
18	55225718	C	T	ENSG00000066926	FECH	ENST00000262093.5:c.804+659G>A	18:g.55225718C>T	7/10	0.0001273600064450875			Erythropoietic Protoporphyria (177000)	pbarbosa_2022
X	100654328	G	A	ENSG00000102393	GLA	ENST00000218516.3:c.640-394C>T	X:g.100654328G>A	4/6	.		57bp_pseudoexon_inclusion	Fabry disease (301500)	pbarbosa_2022
18	2760414	A	G	ENSG00000101596	SMCHD1	ENST00000320876.6:c.4347-236A>G	18:g.2760414A>G	34/47	.	new_splice_acceptor	53bp_pseudoexon_inclusion	Facioscapulohumeral dystrophy (158901)	pbarbosa_2022
13	113770688	C	G	ENSG00000057593	F7	ENST00000375581.3:c.572-392C>G	13:g.113770688C>G	6/8	.	new_splice_donor	282bp_pseudoexon_inclusion	Factor VII deficiency (613878)	pbarbosa_2022
13	113770192	G	A	ENSG00000057593	F7	ENST00000375581.3:c.571+78G>A	13:g.113770192G>A	6/8	.	change_sre	79bp_exon_extension; 79bp_partial_intron_retention	Factor VII deficiency (613878)	pbarbosa_2022
19	11233632	G	A	ENSG00000130164	LDLR	ENST00000558518.1:c.2141-218G>A	19:g.11233632G>A	14/17	.	strengthening_donor	132bp_pseudoexon_inclusion	Familial hypercholesterolemia (143890)	pbarbosa_2022
19	11231301	G	T	ENSG00000130164	LDLR	ENST00000558518.1:c.2140+103G>T	19:g.11231301G>T	14/17	.	strengthening_donor	97bp_exon_extension	Familial hypercholesterolemia (143890)	pbarbosa_2022
X	131231231	A	T	ENSG00000165694	FRMD7	ENST00000298542.4:c.284+63T>A	X:g.131231231A>T	4/11	.	new_splice_acceptor	142bp_pseudoexon_inclusion	FRMD7-related infantile nystagmus (310700)	pbarbosa_2022
X	131221430	T	C	ENSG00000165694	FRMD7	ENST00000298542.4:c.383-1368A>G	X:g.131221430T>C	5/11	.	change_sre	80bp_pseudoexon_inclusion	FRMD7-related infantile nystagmus (310700)	pbarbosa_2022
6	6225105	C	T	ENSG00000124491	F13A1	ENST00000264870.3:c.799-12G>A	6:g.6225105C>T	6/14	.	new_splice_acceptor	10bp_exon_extension	FXIII deficiency (613225)	pbarbosa_2022
9	34649951	A	G	ENSG00000213930	GALT	ENST00000378842.3:c.1059+390A>G	9:g.34649951A>G	10/10	.	new_splice_acceptor	187bp_pseudoexon_inclusion	Galactosemia (230400)	pbarbosa_2022
1	155206890	G	T	ENSG00000177628	GBA	ENST00000327247.5:c.999+242C>A	1:g.155206890G>T	8/11	.	strengthening_donor	239bp_exon_extension	Gaucher Disease (230800)	pbarbosa_2022
11	134011925	G	C	ENSG00000166086	JAM3	ENST00000299106.4:c.256+1260G>C	11:g.134011925G>C	3/8	.	strengthening_acceptor	101bp_pseudoexon_inclusion	HDBSCC (613730)	pbarbosa_2022
X	154175372	C	T	ENSG00000185010	F8	ENST00000360256.4:c.2113+601G>A	X:g.154175372C>T	13/25	.	strengthening_donor	122bp_pseudoexon_inclusion	Hemophilia A (306700)	pbarbosa_2022
X	154130719	C	T	ENSG00000185010	F8	ENST00000360256.4:c.5999-277G>A	X:g.154130719C>T	18/25	.	strengthening_donor	95-bp_pseudoexon_inclusion	Hemophilia A (306700)	pbarbosa_2022
X	154130469	T	C	ENSG00000185010	F8	ENST00000360256.4:c.5999-27A>G	X:g.154130469T>C	18/25	.	branchpoint_associated	exon_skipping	Hemophilia A (306700)	pbarbosa_2022
X	154249118	T	C	ENSG00000185010	F8	ENST00000360256.4:c.143+1567A>G	X:g.154249118T>C	1/25	.	new_splice_donor	191bp_pseudoexon_inclusion	Hemophilia A (306700)	pbarbosa_2022
X	154193643	T	C	ENSG00000185010	F8	ENST00000360256.4:c.1443+602A>G	X:g.154193643T>C	9/25	.	new_splice_acceptor	262bp_pseudoexon_inclusion	Hemophilia A (306700)	pbarbosa_2022
11	57365567	G	T	ENSG00000149131	SERPING1	ENST00000278407.4:c.-22-155G>T	11:g.57365567G>T	1/7	.	new_splice_donor	372bp_exon_extension	Hereditary angioedema (106100)	pbarbosa_2022
11	57374404	A	G	ENSG00000149131	SERPING1	ENST00000278407.4:c.1029+384A>G	11:g.57374404A>G	6/7	.	new_splice_donor	89bp_pseudoexon_inclusion	Hereditary angioedema (106100)	pbarbosa_2022
17	26728068	A	C	ENSG00000076351	SLC46A1	ENST00000440501.1:c.1166-285T>G	17:g.26728068A>C	3/5	.	new_splice_donor	168bp_pseudoexon_inclusion	Hereditary folate malabsorption (229050)	pbarbosa_2022
16	89577853	A	G	ENSG00000197912	SPG7	ENST00000268704.2:c.286+853A>G	16:g.89577853A>G	2/16	.	strengthening_donor	75bp_pseudoexon_inclusion	Hereditary spastic paraplegia (607259)	pbarbosa_2022
11	47361910	C	A	ENSG00000134571	MYBPC3	ENST00000545968.1:c.1928-569G>T	11:g.47361910C>A	20/34	.	new_splice_donor	138bp_pseudoexon_inclusion	Hypertrophic cardiomyopathy (115197)	pbarbosa_2022
11	47368616	C	T	ENSG00000134571	MYBPC3	ENST00000545968.1:c.906-36G>A	11:g.47368616C>T	9/34	.	new_splice_acceptor	34bp_exon_extension;34bp_partial_intron_retention	Hypertrophic cardiomyopathy (115197)	pbarbosa_2022
11	47364865	C	T	ENSG00000134571	MYBPC3	ENST00000545968.1:c.1224-52G>A	11:g.47364865C>T	13/34	3.1914001738186926e-05	new_splice_acceptor	50bp_exon_extension	Hypertrophic cardiomyopathy (115197)	pbarbosa_2022
11	47367305	G	A	ENSG00000134571	MYBPC3	ENST00000545968.1:c.1090+453C>T	11:g.47367305G>A	12/34	.	new_splice_donor	77bp_pseudoexon_inclusion	Hypertrophic cardiomyopathy (115197)	pbarbosa_2022
11	47364893	C	T	ENSG00000134571	MYBPC3	ENST00000545968.1:c.1224-80G>A	11:g.47364893C>T	13/34	6.376700184773654e-05	new_splice_acceptor	78bp_exon_extension;78bp_partial_intron_retention	Hypertrophic cardiomyopathy (115197)	pbarbosa_2022
11	47365750	T	G	ENSG00000134571	MYBPC3	ENST00000545968.1:c.1091-575A>C	11:g.47365750T>G	12/34	.	strengthening_acceptor	85bp_pseudoexon_inclusion	Hypertrophic cardiomyopathy (115197)	pbarbosa_2022
11	47361954	G	A	ENSG00000134571	MYBPC3	ENST00000545968.1:c.1927+600C>T	11:g.47361954G>A	20/34	.	new_splice_donor	94bp_pseudoexon_inclusion	Hypertrophic cardiomyopathy (115197)	pbarbosa_2022
11	47364834	T	C	ENSG00000134571	MYBPC3	ENST00000545968.1:c.1224-21A>G	11:g.47364834T>C	13/34	.	new_splice_acceptor	exon_extension	Hypertrophic cardiomyopathy (115197)	pbarbosa_2022
11	47354550	A	C	ENSG00000134571	MYBPC3	ENST00000545968.1:c.3331-26T>G	11:g.47354550A>C	30/34	.	branchpoint_associated	exon_extension&intron_retention	Hypertrophic cardiomyopathy (115197)	pbarbosa_2022
10	79783995	G	A	ENSG00000148606	POLR3A	ENST00000372371.3:c.645+312C>T	10:g.79783995G>A	5/30	.	new_splice_donor	129bp_pseudoexon_inclusion	Hypomyelinating leukodystrophy (607694)	pbarbosa_2022
12	133251750	C	T	ENSG00000177084	POLE	ENST00000320574.5:c.1226+234G>A	12:g.133251750C>T	12/48	.		106bp_pseudoexon_inclusion&309bp_exon_extension	IMAGE-I syndrome (618336)	pbarbosa_2022
2	15567431	C	G	ENSG00000151779	NBAS	ENST00000281513.5:c.2423+404G>C	2:g.15567431C>G	22/51	6.372699863277376e-05	change_sre	131bp_pseudoexon_inclusion	Infantile liver failure syndrome (616483)	pbarbosa_2022
5	37164443	C	T	ENSG00000197603	CPLANE1	ENST00000425232.2:c.7534-14G>A	5:g.37164443C>T	36/51	.	weakening_acceptor	exon_skipping	Joubert syndrome (614615)	pbarbosa_2022
17	7910183	C	G	ENSG00000132518	GUCY2D	ENST00000254854.4:c.1378+151C>G	17:g.7910183C>G	4/19	.	new_splice_donor		Leber congenital amaurosis (204000)	pbarbosa_2022
14	21789290	T	G	ENSG00000092200	RPGRIP1	ENST00000400017.2:c.1468-128T>G	14:g.21789290T>G	11/23	.	strengthening_donor	118bp_pseudoexon_inclusion	Leber congenital amaurosis (613826)	pbarbosa_2022
8	96048588	C	T	ENSG00000156170	NDUFAF6	ENST00000396124.4:c.420+784C>T	8:g.96048588C>T	3/8	.	strengthening_acceptor	124bp_pseudoexon_inclusion	Leigh syndrome (256000)	pbarbosa_2022
17	79213749	C	T	ENSG00000224877	NDUFAF8	ENST00000431388.2:c.195+271C>T	17:g.79213749C>T	2/2	0.0006052100216038525	strengthening_donor	exon_extension	Leigh syndrome (256000)	pbarbosa_2022
7	150642918	C	A	ENSG00000055118	KCNH2	ENST00000262186.5:c.3331-316G>T	7:g.150642918C>A	14/14	.		89bp_pseudoexon_inclusion	Long QT syndrome (613688)	pbarbosa_2022
15	48737716	C	T	ENSG00000166147	FBN1	ENST00000316623.5:c.5789-15G>A	15:g.48737716C>T	47/65	.	weakening_acceptor	intron_retention	Marfan syndrome (154700)	pbarbosa_2022
21	34957110	C	T	ENSG00000159147	DONSON	ENST00000303071.5:c.607-36G>A	21:g.34957110C>T	3/9	.	new_splice_acceptor	34bp_exon_extension	Meier-Gorlin syndrome (224690)	pbarbosa_2022
3	119234712	A	G	ENSG00000113845	TIMMDC1	ENST00000494664.1:c.597-1340A>G	3:g.119234712A>G	5/6	9.558400051901117e-05	change_sre	80bp_pseudoexon_inclusion	Mitochondrial complex I deficiency (618251)	pbarbosa_2022
16	2010712	G	C	ENSG00000140990	NDUFB10	ENST00000268668.6:c.131-442G>C	16:g.2010712G>C	1/3	.		94bp_pseudoexon_inclusion	Mitochondrial complex I deficiency (619003)	pbarbosa_2022
14	78177003	A	G	ENSG00000119705	SLIRP	ENST00000557342.1:c.98-178A>G	14:g.78177003A>G	1/3	.	new_splice_donor	106bp_pseudoexon_inclusion	Mitochondrial encephalomyopathy (300816)	pbarbosa_2022
2	26502265	A	G	ENSG00000138029	HADHB	ENST00000317799.5:c.811+82A>G	2:g.26502265A>G	9/15	6.374700024025515e-05	new_splice_donor	81bp_exon_extension	Mitochondrial trifunctional protein deficiency (609015)	pbarbosa_2022
16	88898676	T	C	ENSG00000141012	GALNS	ENST00000268695.5:c.899-167A>G	16:g.88898676T>C	8/13	.	new_splice_donor	53bp_pseudoexon_inclusion	Morquio A (253000)	pbarbosa_2022
5	78180826	T	C	ENSG00000113273	ARSB	ENST00000264914.4:c.1142+581A>G	5:g.78180826T>C	5/7	.	new_splice_donor	125bp_pseudoexon_inclusion	Mucopolysaccharidosis (253200)	pbarbosa_2022
2	71900503	C	T	ENSG00000135636	DYSF	ENST00000410020.3:c.5785-824C>T	2:g.71900503C>T	51/55	.	new_splice_donor	180bp_pseudoexon_inclusion	Muscular Dystrophy (253601)	pbarbosa_2022
2	220289644	G	A	ENSG00000175084	DES	ENST00000373960.3:c.1289-741G>A	2:g.220289644G>A	7/8	.	new_splice_acceptor	118bp_pseudoexon_inclusion	Myopathy with cardiac involvement (601419)	pbarbosa_2022
19	39014507	G	A	ENSG00000196218	RYR1	ENST00000359596.3:c.10441-48G>A	19:g.39014507G>A	69/105	.	new_splice_acceptor		Neonatal hypotonia (616034)	pbarbosa_2022
3	132436749	G	C	ENSG00000113971	NPHP3	ENST00000337331.5:c.671-996C>G	3:g.132436749G>C	3/26	.	strengthening_donor	163bp_pseudoexon_inclusion	Nephronophthisis (604387)	pbarbosa_2022
17	29580296	A	G	ENSG00000196712	NF1	ENST00000358273.4:c.4173+278A>G	17:g.29580296A>G	31/57	.	new_splice_acceptor	80bp_pseudoexon_inclusion	Neurofibromatosis (162200)	pbarbosa_2022
18	21114305	T	A	ENSG00000141458	NPC1	ENST00000269228.5:c.3591+105A>T	18:g.21114305T>A	23/24	.	new_splice_donor	103bp_exon_extension	Niemann-Pick disease type C (257220)	pbarbosa_2022
18	21114289	G	A	ENSG00000141458	NPC1	ENST00000269228.5:c.3591+121C>T	18:g.21114289G>A	23/24	.	new_splice_donor	119bp_exon_extension	Niemann-Pick disease type C (257220)	pbarbosa_2022
22	21349779	C	T	ENSG00000099949	LZTR1	ENST00000215739.8:c.1943-256C>T	22:g.21349779C>T	16/20	0.0001597299997229129		intron_retention	Noonan syndrome (605275)	pbarbosa_2022
X	9708630	C	T	ENSG00000101850	GPR143	ENST00000467482.1:c.885+748G>A	X:g.9708630C>T	7/8	.	new_splice_acceptor	165bp_pseudoexon_inclusion	Ocular albinism (300500)	pbarbosa_2022
5	178414570	A	AT	ENSG00000113262	GRM6	ENST00000231188.5:c.1355-587dup	5:g.178414571dup	6/9	.	strengthening_donor	75bp_pseudoexon_inclusion	Oguchi disease (258100)	pbarbosa_2022
3	193362516	A	G	ENSG00000198836	OPA1	ENST00000361908.3:c.1554+622A>G	3:g.193362516A>G	15/29	.	strengthening_donor	54bp_pseudoexon_inclusion	Optic atrophy (165500)	pbarbosa_2022
16	1500379	C	T	ENSG00000103249	CLCN7	ENST00000382745.4:c.1617+119G>A	16:g.1500379C>T	17/24	.	new_splice_acceptor	109bp_pseudoexon_inclusion	Osteopetrosis (611490)	pbarbosa_2022
3	158367854	G	A	ENSG00000168827	GFM1	ENST00000486715.1:c.689+908G>A	3:g.158367854G>A	5/17	.	strengthening_donor	57bp_pseudoexon_inclusion (non canonical isoform activation)	Oxidative Phosphorilation defficiency (609060)	pbarbosa_2022
1	161284289	A	G	ENSG00000143252	SDHC	ENST00000367975.2:c.20+74A>G	1:g.161284289A>G	1/5	.	new_splice_donor	75bp_exon_extension	Paraganglioma (168000)	pbarbosa_2022
22	38509935	C	T	ENSG00000184381	PLA2G6	ENST00000332509.3:c.2035-274G>A	22:g.38509935C>T	14/16	.	strengthening_donor	118bp_pseudoexon_inclusion	Parkinson disease (612953)	pbarbosa_2022
12	103236922	T	A	ENSG00000171759	PAH	ENST00000553106.1:c.1199+502A>T	12:g.103236922T>A	11/12	.	branchpoint_associated	25bp_pseudoexon_inclusion	Phenylketonuria (261600)	pbarbosa_2022
12	103248546	A	G	ENSG00000171759	PAH	ENST00000553106.1:c.706+368T>C	12:g.103248546A>G	6/12	.	change_sre	313bp_pseudoexon_inclusion	Phenylketonuria (261600)	pbarbosa_2022
12	103237873	G	T	ENSG00000171759	PAH	ENST00000553106.1:c.1065+241C>A	12:g.103237873G>T	10/12	.	change_sre	81bp_pseudoexon_inclusion	Phenylketonuria (261600)	pbarbosa_2022
3	10184553	T	C	ENSG00000134086	VHL	ENST00000256474.2:c.340+682T>C	3:g.10184553T>C	1/2	.		259bp_pseudoexon_inclusion	Pheochromocytoma (171300)	pbarbosa_2022
6	35477388	C	T	ENSG00000112041	TULP1	ENST00000229771.6:c.718+23G>A	6:g.35477388C>T	7/14	.	strengthening_donor	20bp_exon_extension	Photoreceptor Dystrophy (602093)	pbarbosa_2022
8	42328683	C	T	ENSG00000168575	SLC20A2	ENST00000342228.3:c.289+937G>A	8:g.42328683C>T	2/10	.	change_sre	38bp_pseudoexon_inclusion	Primary familial brain calcification (213600)	pbarbosa_2022
18	67815044	C	T	ENSG00000176225	RTTN	ENST00000255674.6:c.2309+1093G>A	18:g.67815044C>T	17/48	.	new_splice_acceptor	85bp_pseudoexon_inclusion	Primary microcephaly (614833)	pbarbosa_2022
22	38510587	C	T	ENSG00000184381	PLA2G6	ENST00000332509.3:c.2035-926G>A	22:g.38510587C>T	14/16	.	new_splice_acceptor	145bp_pseudoexon_inclusion	Progressive Neurological disease (610217)	pbarbosa_2022
11	66618867	G	A	ENSG00000173599	PC	ENST00000393960.1:c.1983-116C>T	11:g.66618867G>A	16/22	.	new_splice_donor	pseudoexon_inclusion	Pyruvate carboxylase deficiency (266150)	pbarbosa_2022
X	48758901	G	A	ENSG00000102103	PQBP1	ENST00000218224.4:c.180-306G>A	X:g.48758901G>A	2/5	.	strengthening_donor	pseudoexon_inclusion&intron_retention	Renpenning syndrome (309500)	pbarbosa_2022
17	36494957	C	T	ENSG00000188888	GPR179	ENST00000342292.4:c.903+343G>A	17:g.36494957C>T	2/10	3.18689999403432e-05	new_splice_acceptor	197bp_pseudoexon_inclusion	Retinal dystrophy (614565)	pbarbosa_2022
11	66287067	A	T	ENSG00000174483	BBS1	ENST00000318312.7:c.592-21A>T	11:g.66287067A>T	7/16	.	branchpoint_associated	exon_skipping	Retinitis pigmentosa (600138)	pbarbosa_2022
6	65229204	T	C	ENSG00000188107	EYS	ENST00000503581.1:c.5644+70912A>G	6:g.65229204T>C	26/42	.	new_splice_acceptor	104bp_pseudoexon_inclusion	Retinitis pigmentosa (602772)	pbarbosa_2022
1	216523906	C	A	ENSG00000042781	USH2A	ENST00000307340.3:c.784+14389G>T	1:g.216523906C>A	4/71	0.000478130008559674	strengthening_acceptor	97bp_pseudoexon_inclusion	Retinitis pigmentosa (613809)	pbarbosa_2022
2	112582942	G	A	ENSG00000153107	ANAPC1 	ENST00000341068.3:c.2705-198C>T	2:g.112582942G>A	22/47	6.371500057866797e-05	strengthening_donor	95bp_pseudoexon_inclusion	Rothmund-Thomson syndrome (618625)	pbarbosa_2022
1	94509799	G	A	ENSG00000198691	ABCA4	ENST00000370225.3:c.3050+370C>T	1:g.94509799G>A	20/49	.	new_splice_donor	105bp_pseudoexon_inclusion	Stargardt disease (248200)	pbarbosa_2022
1	94484125	T	C	ENSG00000198691	ABCA4	ENST00000370225.3:c.5196+1013A>G	1:g.94484125T>C	36/49	.	strengthening_donor	129bp_pseudoexon_inclusion	Stargardt disease (248200)	pbarbosa_2022
1	94511126	A	T	ENSG00000198691	ABCA4	ENST00000370225.3:c.2919-826T>A	1:g.94511126A>T	19/49	.	change_sre	133bp_pseudoexon_inclusion	Stargardt disease (248200)	pbarbosa_2022
1	94527698	G	C	ENSG00000198691	ABCA4	ENST00000370225.3:c.1937+435C>G	1:g.94527698G>C	13/49	.	change_sre	134bp_pseudoexon_inclusion	Stargardt disease (248200)	pbarbosa_2022
1	94526934	T	C	ENSG00000198691	ABCA4	ENST00000370225.3:c.1938-619A>G	1:g.94526934T>C	13/49	.	strengthening_donor	174bp_pseudoexon_inclusion & 134bp_pseudoexon_inclusion	Stargardt disease (248200)	pbarbosa_2022
1	94549781	G	A	ENSG00000198691	ABCA4	ENST00000370225.3:c.769-784C>T	1:g.94549781G>A	6/49	0.0028333000373095274	strengthening_acceptor	296bp_pseudoexon_inclusion	Stargardt disease (248200)	pbarbosa_2022
1	94493000	C	T	ENSG00000198691	ABCA4	ENST00000370225.3:c.4539+2001G>A	1:g.94493000C>T	30/49	3.184899833286181e-05	change_sre	345bp_pseudoexon_inclusion	Stargardt disease (248200)	pbarbosa_2022
1	94492973	G	A	ENSG00000198691	ABCA4	ENST00000370225.3:c.4539+2028C>T	1:g.94492973G>A	30/49	6.370600021909922e-05	change_sre	345bp_pseudoexon_inclusion	Stargardt disease (248200)	pbarbosa_2022
1	94546780	C	G	ENSG00000198691	ABCA4	ENST00000370225.3:c.859-506G>C	1:g.94546780C>G	7/49	.	strengthening_acceptor	56bp_pseudoexon_inclusion	Stargardt disease (248200)	pbarbosa_2022
1	94495923	C	T	ENSG00000198691	ABCA4	ENST00000370225.3:c.4352+61G>A	1:g.94495923C>T	29/49	.	strengthening_donor	57bp_exon_extension	Stargardt disease (248200)	pbarbosa_2022
1	94493901	T	C	ENSG00000198691	ABCA4	ENST00000370225.3:c.4539+1100A>G	1:g.94493901T>C	30/49	.	new_splice_donor	68bp_pseudoexon_inclusion	Stargardt disease (248200)	pbarbosa_2022
1	94493895	G	A	ENSG00000198691	ABCA4	ENST00000370225.3:c.4539+1106C>T	1:g.94493895G>A	30/49	.	strengthening_donor	68bp_pseudoexon_inclusion	Stargardt disease (248200)	pbarbosa_2022
1	94484001	C	T	ENSG00000198691	ABCA4	ENST00000370225.3:c.5196+1137G>A	1:g.94484001C>T	36/49	9.558400051901117e-05	strengthening_acceptor	73bp_pseudoexon_inclusion	Stargardt disease (248200)	pbarbosa_2022
1	94483922	G	T	ENSG00000198691	ABCA4	ENST00000370225.3:c.5196+1216C>A	1:g.94483922G>T	36/49	.	strengthening_donor	73bp_pseudoexon_inclusion	Stargardt disease (248200)	pbarbosa_2022
1	94546299	T	C	ENSG00000198691	ABCA4	ENST00000370225.3:c.859-25A>G	1:g.94546299T>C	7/49	.	branchpoint_associated	exon_skipping&intron_retention	Stargardt disease (248200)	pbarbosa_2022
1	94496509	C	T	ENSG00000198691	ABCA4	ENST00000370225.3:c.4253+43G>A	1:g.94496509C>T	28/49	0.0044921999797225	change_sre	possible_pe_inclusion(experiments not performed) or exon_skip	Stargardt disease (248200)	pbarbosa_2022
1	94525509	T	C	ENSG00000198691	ABCA4	ENST00000370225.3:c.2160+584A>G	1:g.94525509T>C	14/49	.		pseudoexon_inclusion	Stargardt disease (248200)	pbarbosa_2022
12	48393958	G	C	ENSG00000139219	COL2A1	ENST00000380518.3:c.86-50C>G	12:g.48393958G>C	1/53	.	new_splice_acceptor	49bp_exon_extension	Stickler syndrome (108300)	pbarbosa_2022
12	48379984	C	T	ENSG00000139219	COL2A1	ENST00000380518.3:c.1527+135G>A	12:g.48379984C>T	23/53	.	new_splice_acceptor	234bp_pseudoexon_inclusion	Stickler syndrome (108300)	pbarbosa_2022
11	112100215	A	T	ENSG00000150787	PTS	ENST00000280362.3:c.164-716A>T	11:g.112100215A>T	2/5	.	strengthening_donor	70bp_pseudoexon_inclusion	Tetrahydrobiopterin deficiency (261640)	pbarbosa_2022
11	112098994	A	T	ENSG00000150787	PTS	ENST00000280362.3:c.84-323A>T	11:g.112098994A>T	1/5	.	strengthening_acceptor	79bp_pseudoexon_inclusion	Tetrahydrobiopterin deficiency (261640)	pbarbosa_2022
11	112100259	C	T	ENSG00000150787	PTS	ENST00000280362.3:c.164-672C>T	11:g.112100259C>T	2/5	9.7720003395807e-05	new_splice_donor	pseudoexon_inclusion	Tetrahydrobiopterin deficiency (261640)	pbarbosa_2022
21	47409881	C	T	ENSG00000142156	COL6A1	ENST00000361866.3:c.930+189C>T	21:g.47409881C>T	11/34	.	new_splice_donor	72bp_pseudoexon_inclusion	Ullrich congenital muscular dystrophy (120220)	pbarbosa_2022
1	216041166	G	C	ENSG00000042781	USH2A	ENST00000307340.3:c.8682-654C>G	1:g.216041166G>C	43/71	3.183499939041212e-05	strengthening_donor	129bp_pseudoexon_inclusion	Usher syndrome (276901)	pbarbosa_2022
1	216064540	T	C	ENSG00000042781	USH2A	ENST00000307340.3:c.7595-2144A>G	1:g.216064540T>C	40/71	6.368199683493003e-05	new_splice_donor	152bp_pseudoexon_inclusion	Usher syndrome (276901)	pbarbosa_2022
3	150660197	A	C	ENSG00000163646	CLRN1	ENST00000328863.4:c.254-649T>G	3:g.150660197A>C	1/3	.	new_splice_donor	230bp_pseudoexon_inclusion	Usher syndrome (276902)	pbarbosa_2022
5	90099416	A	G	ENSG00000164199	ADGRV1	ENST00000405460.2:c.14661+717A>G	5:g.90099416A>G	71/89	.	new_splice_donor	119bp_pseudoexon_inclusion	Usher syndrome (605472)	pbarbosa_2022
3	10184488	C	G	ENSG00000134086	VHL	ENST00000256474.2:c.340+617C>G	3:g.10184488C>G	1/2	.	change_sre	259bp_pseudoexon_inclusion	Von Hippel-Lindau syndrome (193300)	pbarbosa_2022
3	10184519	T	C	ENSG00000134086	VHL	ENST00000256474.2:c.340+648T>C	3:g.10184519T>C	1/2	0.013094999827444553		259bp_pseudoexon_inclusion	Von Hippel-Lindau syndrome (193300)	pbarbosa_2022
12	6182667	A	C	ENSG00000110799	VWF	ENST00000261405.5:c.997+118T>G	12:g.6182667A>C	8/51	.	new_splice_donor	118bp_exon_extension	Willebrand disease (193400)	pbarbosa_2022
13	52534477	A	T	ENSG00000123191	ATP7B	ENST00000242839.4:c.1947-19T>A	13:g.52534477A>T	6/20	.	strengthening_acceptor	exon_skipping&exon_extension	Wilson disease (277900)	pbarbosa_2022
13	52522135	C	T	ENSG00000123191	ATP7B	ENST00000242839.4:c.2866-1521G>A	13:g.52522135C>T	12/20	.	new_splice_acceptor		Wilson disease (277900)	pbarbosa_2022
X	149831329	A	G	ENSG00000171100	MTM1	ENST00000370396.2:c.1468-577A>G	X:g.149831329A>G	13/14	.	strengthening_donor	48bp_pseudoexon_inclusion	X-linked myotubular myopathy (310400)	pbarbosa_2022
X	24744696	A	G	ENSG00000101868	POLA1	ENST00000379059.3:c.1375-354A>G	X:g.24744696A>G	13/36	.	new_splice_donor	76bp_pseudoexon_inclusion	X-linked reticulate pigmentary disorder (301220)	pbarbosa_2022
